The OpenAI Foundation is finalizing over $100 million in Alzheimer’s research grants this month, part of a $1 billion commitment by 2026. The grants focus on using AI for drug design, biomarker development, and disease progression tracking. This shift in focus represents a significant investment in AI in science.

Leave a Reply